Cover Image
Read Now

Trimebutine maleate and pinaverium bromide for irritable bowel syndrome a review of the clinical effectiveness, safety and guidelines

The purpose of this report is to review the clinical effectiveness and safety of trimebutine maleate and pinaverium bromide for the treatment of adult and adolescent patients with irritable bowel syndrome (IBS) and to review the evidence-based guidelines on the use of these two agents for IBS.

Bibliographic Details
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa (ON) CADTH Rapid Response Service 2015, 30 November 2015
Series:Rapid response report: summary with critical appraisal
Subjects:
Gastrointestinal Agents / Therapeutic Use
Drug Monitoring
Parasympatholytics / Therapeutic Use
Treatment Outcome
Irritable Bowel Syndrome / Drug Therapy
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The purpose of this report is to review the clinical effectiveness and safety of trimebutine maleate and pinaverium bromide for the treatment of adult and adolescent patients with irritable bowel syndrome (IBS) and to review the evidence-based guidelines on the use of these two agents for IBS.
Physical Description:1 PDF file (25 pages) illustration

Similar Items